DOAC (direct oral anticoagulant)

Notification of initiation and transfer of care/prescribing

The DOAC notification of initiation and transfer of care /prescribing agreements for the following are located under policies:

  • Stroke prevention in non-valvular atrial fibrillation
  • Acute treatment or secondary prevention of venous thromboembolism
  • Acute coronary syndrome (rivaroxaban)

Prescribing Guidance

The ‘Anticoagulation selection for stroke prevention in non-valvular atrial fibrillation (NVAF) in adults’ document is currently under review and will be published in due course.

    DOAC: Initiation in non-valvular atrial fibrillation (NVAF) and monitoring in all indications

    DOAC: Rivaroxaban – for acute coronary syndrome

    DOAC: Safe Switching of Warfarin to DOAC for non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) – during coronavirus pandemic

    DOAC: Calculating renal function

    DOAC: Frequently asked questions for primary care